As impressive as AI's potential in drug development and medical care are, it's worth a reminder that both of these systems are highly sclerotic, and that drug development in particular requires a lengthy clinical testing process. As a result, they're unlikely to be the biggest impact on our daily lives (particularly in the shorter part of that time period, the longer may have slightly more point).

​

In practice, there are a few areas where people are more likely to interact with AI significantly in the range we're discussing here. Basically they're automation/robotics, and software. And the latter will be much faster than the former (which is still going to take substantial rollout time). Nonetheless, one of the growing indicators is the gradual rollout we're seeing of robotaxis. Which will likely be endemic within cities by then.